Trial Profile
A Study of Combined Coronary Artery Bypass Grafting (CABG) and Blood-Borne Autologous Angiogenic Cell Precursors Therapy in Patients With Congestive Heart Failure Due to Ischemic Heart Disease
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs ACP 01 (Primary)
- Indications Heart failure
- Focus Adverse reactions; Therapeutic Use
- Acronyms ACPs-CHF
- Sponsors TheraVitae
- 05 Jun 2014 New trial record